However, irrespective of the mutational status, AML cells show increased activation of the Cyclin D-CDK4/CDK6 complex [14], suggesting that the deregulation of the CDK/RB axis is a hallmark of AML. This evidence concerns the gene CDK6 and acute myeloid leukemia.